Literature DB >> 7668030

Induction of a secretory IgA response in the murine female urogenital tract by immunization of the lungs with liposome-supplemented viral subunit antigen.

A de Haan1, K B Renegar, P A Small, J Wilschut.   

Abstract

This study demonstrates that liposomes administered to the lower respiratory tract of mice have the capacity to stimulate secretory IgA (s-IgA) antibody production in the female urogenital system. Total respiratory tract immunization of mice with influenza virus subunit antigen simply mixed with negatively charged liposomes induced antigen-specific s-IgA in vaginal secretions, in addition to systemic IgG and s-IgA in the respiratory tract. Immunization of the upper respiratory tract alone or oral immunization were ineffective. These observations demonstrate that, upon stimulation with liposomes, the lymphoid tissue associated with the lung can act as an inductive site for migration of IgA-committed B cells to distant mucosal tissues, including the female urogenital tract. It is concluded that liposomes administered to the lower respiratory tract provide a promising adjuvant system for stimulation of both systemic and mucosal antibody responses against coadministered antigen, including production of s-IgA at distant mucosal sites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668030     DOI: 10.1016/0264-410x(94)00062-r

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.

Authors:  N K Childers; K L Miller; G Tong; J C Llarena; T Greenway; J T Ulrich; S M Michalek
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages.

Authors:  A de Haan; G Groen; J Prop; N van Rooijen; J Wilschut
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.

Authors:  C Balmelli; R Roden; A Potts; J Schiller; P De Grandi; D Nardelli-Haefliger
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induces neutralizing titers of antibodies throughout the estrous cycle of mice.

Authors:  D Nardelli-Haefliger; R Roden; C Balmelli; A Potts; J Schiller; P De Grandi
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccines.

Authors:  Libuse Janakova; Hilde Bakke; Inger Lise Haugen; Aud K H Berstad; E Arne Høiby; Ingeborg S Aaberge; Bjørn Haneberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

6.  Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses.

Authors:  R A Guerrero; J M Ball; S S Krater; S E Pacheco; J D Clements; M K Estes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Oral Delivery of Probiotics Expressing Dendritic Cell-Targeting Peptide Fused with Porcine Epidemic Diarrhea Virus COE Antigen: A Promising Vaccine Strategy against PEDV.

Authors:  Xiaona Wang; Li Wang; Xuewei Huang; Sunting Ma; Meiling Yu; Wen Shi; Xinyuan Qiao; Lijie Tang; Yigang Xu; Yijing Li
Journal:  Viruses       Date:  2017-10-25       Impact factor: 5.048

8.  Immunogenicity of a neutralizing epitope from porcine epidemic diarrhea virus: M cell targeting ligand fusion protein expressed in transgenic rice calli.

Authors:  Nguyen-Xuan Huy; Sae-Hae Kim; Moon-Sik Yang; Tae-Geum Kim
Journal:  Plant Cell Rep       Date:  2012-06-27       Impact factor: 4.570

9.  Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration.

Authors:  Natalija Budimir; Aalzen de Haan; Tjarko Meijerhof; Emma Gostick; David A Price; Anke Huckriede; Jan Wilschut
Journal:  Influenza Other Respir Viruses       Date:  2013-09-16       Impact factor: 4.380

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.